CRTHF (CARsgen Therapeutics Holdings) ROE % Adjusted to Book Value: -0.61% (As of Dec. 2025)


CRTHF CARsgen Therapeutics Holdings Ltd CRTHF
24 GF Score
Price $2.09
! 3 Warning Signs
View Full Analysis

What is CARsgen Therapeutics Holdings ROE % Adjusted to Book Value?

CARsgen Therapeutics Holdings CRTHF +0.67% 24 ROE % Adjusted to Book Value is -0.61% as of Dec. 2025. GuruFocus rates CRTHF with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

CARsgen Therapeutics Holdings's ROE % for the quarter that ended in Dec. 2025 was -5.22%. CARsgen Therapeutics Holdings's PB Ratio for the quarter that ended in Dec. 2025 was 8.55. CARsgen Therapeutics Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -0.61%.

CARsgen Therapeutics Holdings ROE % Adjusted to Book Value Related Terms

CARsgen Therapeutics Holdings ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for CARsgen Therapeutics Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARsgen Therapeutics Holdings ROE % Adjusted to Book Value Chart

CARsgen Therapeutics Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 -10.66 -9.35 -19.15 -1.27

CARsgen Therapeutics Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.30 -20.92 -24.23 -4.79 -0.61

CRTHF vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, CARsgen Therapeutics Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CARsgen Therapeutics Holdings ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CARsgen Therapeutics Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CARsgen Therapeutics Holdings's ROE % Adjusted to Book Value falls into.


CRTHF
24GF Score
CARsgen Therapeutics Holdings Ltd CRTHF
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARsgen Therapeutics Holdings ROE % Adjusted to Book Value Calculation

CARsgen Therapeutics Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-10.84% / 8.55
=-1.27%

CARsgen Therapeutics Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-5.22% / 8.55
=-0.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -0.61% mean?
CARsgen Therapeutics Holdings (CRTHF) has a ROE % Adjusted to Book Value of -0.61% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on CARsgen Therapeutics Holdings and its competitors.
Is CARsgen Therapeutics Holdings' ROE % Adjusted to Book Value too high?
CARsgen Therapeutics Holdings' current ROE % Adjusted to Book Value is -0.61%. Overall, CARsgen Therapeutics Holdings has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does CARsgen Therapeutics Holdings' ROE % Adjusted to Book Value compare to VRTX and REGN?
CARsgen Therapeutics Holdings' ROE % Adjusted to Book Value of -0.61% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on CARsgen Therapeutics Holdings and its competitors. CARsgen Therapeutics Holdings's current ROE % Adjusted to Book Value is -0.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARsgen Therapeutics Holdings stock overvalued right now?
CARsgen Therapeutics Holdings (CRTHF) has a current ROE % Adjusted to Book Value of -0.61%. The current ROE % Adjusted to Book Value is -0.61%. CARsgen Therapeutics Holdings' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For CARsgen Therapeutics Holdings (CRTHF), the current ROE % Adjusted to Book Value is -0.61% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CARsgen Therapeutics Holdings Business Description

Other Exchanges 02171:Hong Kong
Address No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
24GF Score

Get the complete analysis for CRTHF

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.09
Price